CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
End Stage Renal Disease | Chronic Kidney Disease Stage 5The main purpose of this trial is to determine whether the addition of the VIEWER virtual care platform to usual care will lead to a reduction in composite emergency department (ED) visits and/or hospitalizations/or increase the perceived safety of virtual care among patients and providers.
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
18 and up
Participation Criteria
Inclusion Criteria:
* \>18 years of age
* Patient or primary caregiver can read and speak English
* Patient or patients substitute decision maker is able to provide informed consent
* Patient or primary care giver cognitively and physically capable and willing to use the VIEWER mobile application and perform self-measurements (i.e. weight, BP, etc.)
* Have stage 5 CKD (2 measurements of eGFR \<15ml/min/1.73m2); eGFR will be calculated with the CKD-EPI equation.
* Followed in a multidisciplinary CKD clinic
* Have \>40% chance of beginning dialysis in the next 2 years based on the Kidney Failure Risk Equation
Exclusion Criteria:
* Inability of self or caregiver assisted self-monitoring using VIEWER
Study Location
Chronic Disease Innovation Centre, Seven Oaks Hospital
Chronic Disease Innovation Centre, Seven Oaks HospitalWinnipeg, Manitoba
Canada
Contact Study Team
Reid Whitlock
London Health Sciences Centre
London Health Sciences CentreLondon, Ontario
Canada
Contact Study Team
Kathleen Koyle
Scarborough Health Network - General Hospital
Scarborough Health Network - General HospitalScarborough, Ontario
Canada
Contact Study Team
Harika Kuppala
- Study Sponsored By
- University of Manitoba
- Participants Required
- More Information
- Study ID:
NCT05726526